⌘K

Login Start Free

Home/Filings/4/0001415889-23-010721

4//SEC Filing

Singh Shawn 4

Accession 0001415889-23-010721

CIK 0001411685other

View on SEC.gov Company Profile

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 4:05 PM ET

Size

5.7 KB

Accession

0001415889-23-010721

Insider Transaction Report

Form 4

Period: 2023-06-30

Vistagen Therapeutics, Inc.VTGN

DirectorCHIEF EXECUTIVE OFFICER

Transactions

Award
Common Stock
2023-06-30$1.59/sh+167$265→ 5,466 total

Holdings

Common Stock
(indirect: By Trust)
20,875

Footnotes (1)

[F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan ("ESPP").

Documents

1 file

4
form4-07052023_040705.xmlPrimary

Issuer

Vistagen Therapeutics, Inc.

CIK 0001411685

Entity typeother

Related Parties

1

filerCIK 0001412071

Filing Metadata

Form type: 4
Filed: Jul 4, 8:00 PM ET
Accepted: Jul 5, 4:05 PM ET
Size: 5.7 KB

View on SEC.gov